874668-59-4 Usage
Uses
Used in Pharmaceutical Industry:
2-(6-AMINO-1H-INDAZOL-1-YL)ETHANOL is used as a building block for the synthesis of biologically active molecules, facilitating the development of new drugs that target specific biological pathways. Its role in drug discovery is crucial for creating innovative therapeutic agents.
Used in Research Applications:
In research, 2-(6-AMINO-1H-INDAZOL-1-YL)ETHANOL is utilized as a reagent in organic synthesis, contributing to the advancement of chemical knowledge and the creation of novel chemical entities.
Used in Antiviral and Anticancer Drug Development:
2-(6-AMINO-1H-INDAZOL-1-YL)ETHANOL is studied for its potential antiviral and anticancer properties, indicating its use as a precursor in the development of treatments for viral infections and cancer.
Used as a Fluorescent Probe in Biomolecular Detection:
2-(6-AMINO-1H-INDAZOL-1-YL)ETHANOL is employed as a fluorescent probe for detecting certain biomolecules, which is instrumental in biological research and diagnostics, allowing for the observation and analysis of specific biological processes at the molecular level.
Check Digit Verification of cas no
The CAS Registry Mumber 874668-59-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,4,6,6 and 8 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 874668-59:
(8*8)+(7*7)+(6*4)+(5*6)+(4*6)+(3*8)+(2*5)+(1*9)=234
234 % 10 = 4
So 874668-59-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H11N3O/c10-8-2-1-7-6-11-12(3-4-13)9(7)5-8/h1-2,5-6,13H,3-4,10H2
874668-59-4Relevant academic research and scientific papers
1-((S)-2-aminopropyl)-1H-indazol-6-ol: A potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity
May, Jesse A.,Dantanarayana, Anura P.,Zinke, Paul W.,McLaughlin, Marsha A.,Sharif, Najam A.
, p. 318 - 328 (2007/10/03)
Serotonin 5-HT2 receptor agonists have been identified as a potential new class of agents for the treatment of ocular hypertension and glaucoma. The initially reported tryptamine analogues displayed either poor solution stability, potent centra
